Rolf F. Richter

Berlin, BE 13353, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Functional traits explain growth response to successive hotter droughts across a wide set of common and future tree species in Europe.

Functional traits explain growth response to successive hotter droughts across a wide set of common and future tree species in Europe.

Journal: Plant biology (Stuttgart, Germany)

Published: December 28, 2024

Sexuality as a Prognostic Factor-Results of an Individual Patient Data NOGGO (North-Eastern German Society of Gynecological Oncology)-Meta-Analysis of 644 Recurrent Ovarian Cancer Patients Prior to Chemotherapy.

Sexuality as a Prognostic Factor-Results of an Individual Patient Data NOGGO (North-Eastern German Society of Gynecological Oncology)-Meta-Analysis of 644 Recurrent Ovarian Cancer Patients Prior to Chemotherapy.

Journal: Cancers

Published: January 09, 2024

Pre-Operative Malnutrition in Patients with Ovarian Cancer: What Are the Clinical Implications? Results of a Prospective Study.

Pre-Operative Malnutrition in Patients with Ovarian Cancer: What Are the Clinical Implications? Results of a Prospective Study.

Journal: Cancers

Published: November 09, 2023

Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.

Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 09, 2023

Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ).

Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ).

Journal: Journal of cancer research and clinical oncology

Published: December 23, 2022

Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis.

Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis.

Journal: Cancer chemotherapy and pharmacology

Published: November 25, 2022

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer.

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer.

Journal: Frontiers in oncology

Published: August 08, 2022

Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.

Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 31, 2022

Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer.

Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer.

Journal: Anticancer research

Published: January 26, 2022

Correction to: Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study.

Correction to: Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study.

Journal: Archives of gynecology and obstetrics

Published: November 19, 2021

HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.

HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.

Journal: BMC cancer

Published: November 15, 2021

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Journal: Annals of surgical oncology

Published: September 30, 2021

Showing 1-12 of 106

Last Updated: 09/26/2026